EN
The aim these investigations was to test the therapeutic effectiveness and safety of CoribanR applied in lambs infected experimentally with Fasciola hepatica. Post-mortem examinations showed high effectiveness of this drug, mainly in young forms of F. hepatica beginning from the third day of invasion. Hematological and biological examinations carried out during the experiment indirectly confirmed, not only the high effectiveness of CoribanR, but also, evidence that there were no side effects in the animals that were treated.